(Q57844416)

1

0 references

Karen Doyle

2

0 references

Camilla Langan

3

0 references

Colm McDonald

4

0 references

Brian Leonard

Translational neuroscience

5

0 references

publication date

1 January 2011

0 references

published in

0 references

volume

2

0 references

issue

2

0 references

exact match

https://scigraph.springernature.com/pub.10.2478/s13380-011-0019-0

0 references

cites work

The Structure of Genetic and Environmental Risk Factors for Common Psychiatric and Substance Use Disorders in Men and Women

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Immune System and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The immune system, depression and the action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammation and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammatory cytokines in vascular dysfunction and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammation in neurodegenerative disease--a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammation in neuropsychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Th1, Th2, and Th3 cytokine alterations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Alpha-1-antichymotrypsin polymorphism in schizophrenia: frequency, age at onset and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Activation of brain interleukin-1beta in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Altered levels of acute phase proteins in the plasma of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Longitudinal study of beta2-microglobulin abnormalities in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A detailed examination of cytokine abnormalities in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Th1, Th2 and Th3 cytokine alteration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Immune variations in bipolar disorder: phasic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A family-based study of the IL3RA gene on susceptibility to schizophrenia in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Functional polymorphism of the myeloperoxidase gene (G-463A) in depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Leukemia inhibitory factor gene is associated with schizophrenia and working memory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine-induced sickness behaviour: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

"Inflammatory" cytokines: neuromodulators in normal brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Pathways and mechanisms for cytokine signaling of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The blood-brain barrier in psychoneuroimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The cerebral microvasculature in schizophrenia: a laser capture microdissection study

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Long-term psychiatric disorders after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Psychosis secondary to traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

CNS immune privilege: hiding in plain sight

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The role of cytokines in the regulation of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The neuropoietic cytokine family in development, plasticity, disease and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Is damage in central nervous system due to inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Glia as a source of cytokines: implications for neuronal excitability and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Neuroinflammation in schizophrenia-related psychosis: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Peripheral and central proinflammatory cytokine response to a severe acute stressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Causal relationship between stressful life events and the onset of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Bcl-2 family regulation of neuronal development and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Mechanisms of caspase activation and inhibition during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Molecular regulation of inflammation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Bcl-2 promotes regeneration of severed axons in mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The HPA axis in major depression: classical theories and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokines as modulators of the hypothalamus-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Depressive disorders and immunity: 20 years of progress and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

BDNF in schizophrenia, depression and corresponding animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Role of glutamate in schizophrenia: integrating excitatory avenues of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The NMDA receptor as a therapeutic target in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The effects of memantine on prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The current status of the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Novel therapies for schizophrenia: understanding the glutamatergic synapse and potential targets for altering N-methyl-D-aspartate neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The kynurenine pathway of tryptophan degradation as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Tolerance, DCs and tryptophan: much ado about IDO

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Increased cortical kynurenate content in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Voltammetric study of the control of striatal dopamine release by glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Nitric oxide negatively regulates mammalian adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

"Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Variants in Apaf-1 segregating with major depression promote apoptosome function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

An inflammatory review of glucocorticoid actions in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Is impaired neurogenesis relevant to the affective symptoms of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Maternal infections and subsequent psychosis among offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The neurodevelopmental model of schizophrenia: update 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The developmental neurobiology of autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Maternal immune activation alters fetal brain development through interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

The concept of depression as a dysfunction of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Evidence for activation of microglia in patients with psychiatric illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Magnetic-resonance morphometry in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Smaller frontal lobe white matter volumes in depressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Inflammation, depression and dementia: are they connected?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Pathways linking depression, adiposity, and inflammatory markers in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Anti-inflammatory drugs in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Association of an Interleukin-1β Genetic Polymorphism With Altered Brain Structure in Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS13380-011-0019-0